Lymphocyte count decreased in Cyclophosphamide - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Lymphocyte count decreased, when it was recovered, drug effectiveness, race, and more among people who take Cyclophosphamide (cyclophosphamide). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Cyclophosphamide?

Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.

What is Lymphocyte count decreased?

Lymphocyte count decreased is found to be associated with 1,205 drugs and 1,336 conditions by eHealthMe. Check the latest studies of Lymphocyte count decreased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

1 person who has Lymphocyte count decreased while taking Cyclophosphamide was studied.

Could Cyclophosphamide cause Lymphocyte count decreased?

Severity of Lymphocyte count decreased *:

least: 0.0 %
moderate: 100 %
severe: 0.0 %
most severe: 0.0 %

When people recovered from Lymphocyte count decreased *:

while on drug: 0.0 %
after off the drug: 0.0 %
not yet: 100 %

Effectiveness of Cyclophosphamide *:

not at all: 0.0 %
somewhat: 0.0 %
moderate: 100 %
high: 0.0 %
very high: 0.0 %

Race of the people *:

African American, Non-Hispanic: 0.0 %
American Indian/Alaska Native: 0.0 %
Asian: 0.0 %
Hispanic: 0.0 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 0.0 %
White, Non-Hispanic: 100 %

Time on Cyclophosphamide *:

Gender of people when taking Cyclophosphamide *:

female: 0.0 %
male: 100 %

Age of people when taking Cyclophosphamide *:

Conditions people have *:

Wegener's Granulomatosis (inflammation of the blood vessels lungs sinuses): 1 person, 100.00%

Other drugs people take besides Cyclophosphamide *:

Prednisone: 1 person, 100.00%

Other side effects people have besides Lymphocyte count decreased *:

Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cyclophosphamide and have Lymphocyte count decreased?

Check whether Lymphocyte count decreased is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Lymphocyte count decreased in Cyclophosphamide

How the study uses the data?

The study is based on cyclophosphamide (the active ingredients of Cyclophosphamide). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.